These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25759938)

  • 1. Regulatory Framework, Challenges, and Initial Strategic Planning for Advanced Therapy Products (PTAs) Development in Brazil.
    Fachel FNS; Schuh RS; Grudzinski PB; Teixeira HF; Baldo G; Matte U
    Ther Innov Regul Sci; 2024 Jan; 58(1):21-33. PubMed ID: 37815738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action, potency and efficacy: considerations for cell therapies.
    Simon CG; Bozenhardt EH; Celluzzi CM; Dobnik D; Grant ML; Lakshmipathy U; Nebel T; Peltier L; Ratcliffe A; Sherley JL; Stacey GN; Taghizadeh RR; Tan EHP; Vessillier S
    J Transl Med; 2024 May; 22(1):416. PubMed ID: 38698408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertainty and innovation: Understanding the role of cell-based manufacturing facilities in shaping regulatory and commercialization environments.
    Isasi R; Rahimzadeh V; Charlebois K
    Appl Transl Genom; 2016 Dec; 11():27-39. PubMed ID: 28018847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forging the Fate of Cellular Therapies for Cardiovascular Disease.
    Simari RD
    Circ Res; 2017 Jun; 120(12):1871-1873. PubMed ID: 28596173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.
    Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N
    PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem Cells.
    Chapman KM; Medrano GA; Jaichander P; Chaudhary J; Waits AE; Nobrega MA; Hotaling JM; Ober C; Hamra FK
    Cell Rep; 2015 Mar; 10(11):1828-35. PubMed ID: 25772367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis.
    Pripuzova NS; Getie-Kebtie M; Grunseich C; Sweeney C; Malech H; Alterman MA
    Stem Cell Res; 2015 May; 14(3):323-38. PubMed ID: 25840413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy and safety outcomes of transplantation of induced pluripotent stem cell-derived neurospheres with bioabsorbable nerve conduits for peripheral nerve regeneration in mice.
    Uemura T; Ikeda M; Takamatsu K; Yokoi T; Okada M; Nakamura H
    Cells Tissues Organs; 2014; 200(1):78-91. PubMed ID: 25823624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs.
    Feng W; Dai Y; Mou L; Cooper DK; Shi D; Cai Z
    Int J Mol Sci; 2015 Mar; 16(3):6545-56. PubMed ID: 25807262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on Challenges to Cell Therapy Development in Taiwan: Strengthening Evidential Standards and Ways Forward.
    Abolarinwa BA; Shaw MK; Lee CH
    Front Bioeng Biotechnol; 2021; 9():789043. PubMed ID: 34976978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Cell- and Tissue-Based Therapeutic Products in Singapore.
    Kellathur SN
    Tissue Eng Part A; 2015 Dec; 21(23-24):2802-5. PubMed ID: 26096855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea.
    Choi M; Han E; Lee S; Kim T; Shin W
    Adv Exp Med Biol; 2015; 871():163-79. PubMed ID: 26374218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Translation of Cell Therapy, Tissue Engineering, and Regenerative Medicine Product in Malaysia and Its Regulatory Policy.
    Bt Hj Idrus R; Abas A; Ab Rahim F; Saim AB
    Tissue Eng Part A; 2015 Dec; 21(23-24):2812-6. PubMed ID: 26192075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Current State of Advanced Therapy Medicinal Products in the Czech Republic.
    Kočí Z; Boráň T; Krůpa P; Kubinová Š
    Hum Gene Ther Clin Dev; 2018 Sep; 29(3):132-147. PubMed ID: 29869533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Regenerative Medicine Products.
    Gee AP
    Adv Exp Med Biol; 2018; 1098():189-198. PubMed ID: 30238372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation Policy on Cell- and Tissue-Based Therapy Products in Korea.
    Lim JO
    Tissue Eng Part A; 2015 Dec; 21(23-24):2791-6. PubMed ID: 25759938
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.